Kenya - English - Pharmacy and Poisons Board

wockhardt limited wockhardt tower bandra-kurla complex bandra east - terbutaline sulphate bromhexine hcl guaifenesin… - oral liquid - each 10 ml contains:terbutaline sulphate bp 2.5… - expectorants excluding combinations with cough

Kenya - English - Pharmacy and Poisons Board

finecure pharmaceuticals ltd village shimla pistaur malsa rd, kichha udha m - terbutaline sulfate, bromhexine hcl, guaifenesin,… - syrup - terbutaline 1.25mg, bromhexine 2mg, guaiphenesin… - combinations

Kenya - English - Pharmacy and Poisons Board

blue cross laboratories ltd a-12 m.i.d.c. ambad nashik maharashtra 422 010 - terbutaline sulphate bromhexine hydrochloride &… - oral liquid - terbutaline sulphate 1.25 mg bromhexine… - adrenergics inhalants:

United States - English - NLM (National Library of Medicine)

rebel distributors corp - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 2.5 mg - terbutaline sulfate is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. terbutaline sulfate is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection, usp is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. 1. prolonged tocolysis terbutaline sulfate has not been approved and should not be used for prolonged tocolysis (beyond 48-72 hours). in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting (see boxed warning: prolonged tocolysis ). 2. hypersensitivity terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 5 mg - terbutaline sulfate is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. 1. tocolysis oral terbutaline sulfate has not been approved and should not be used for acute or maintenance tocolysis. [see boxed warning: tocolysis . ] 2. hypersensitivity terbutaline sulfate is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

United States - English - NLM (National Library of Medicine)

athenex pharmaceutical division, llc. - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. - prolonged tocolysis terbutaline sulfate has not been approved for and should not be used for prolonged tocolysis (beyond 48 to 72 hours). in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting [see boxed warning, prolonged tocolysis ]. - hypersensitivity terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

United States - English - NLM (National Library of Medicine)

united biomedical inc., asia - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 1 mg in 1 ml - terbutaline sulfate injection, usp is indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. terbutaline sulfate has not been approved and should not be used for prolonged tocolysis (beyond 48 to 72 hours).  in particular, terbutaline sulfate should not be used for maintenance tocolysis in the outpatient or home setting (see boxed warning : prolonged tocolysis ). terbutaline sulfate injection is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any component of this drug product.

United States - English - NLM (National Library of Medicine)

amneal pharmaceuticals of new york llc - terbutaline sulfate (unii: 576pu70y8e) (terbutaline - unii:n8onu3l3pg) - terbutaline sulfate 2.5 mg - terbutaline sulfate tablets are indicated for the prevention and reversal of bronchospasm in patients 12 years of age and older with asthma and reversible bronchospasm associated with bronchitis and emphysema. oral terbutaline sulfate has not been approved and should not be used for acute or maintenance tocolysis (see boxed warning: tocolysis ). terbutaline sulfate is contraindicated in patients known to be hypersensitive to sympathomimetic amines or any components of this drug product.